Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)
新辅助治疗期间残余病灶(RD)生物学和基因表达变化对HER2阳性早期乳腺癌(EBC)患者的预后价值
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2024.12.010
Fernandez-Martinez, A; Tanioka, M; Ahn, S G; Zagami, P; Pascual, T; Rediti, M; Tang, G; Hoadley, K A; Venet, D; Rashid, N U; Spears, P A; Di Cosimo, S; de Azambuja, E; Choudhury, A; Rastogi, P; Islam, M N; Cortes, J; Llombart-Cussac, A; Swain, S M; Sotiriou, C; Prat, A; Perou, C M; Carey, L A